An analyst initiated coverage of Thermo Fisher Scientific, causing a 2% increase in stock price the next day. William Blair analyst ranked the healthcare company as outperform, citing competitive advantages. Despite a dip in biopharma clients, Thermo Fisher is well-positioned for growth. Second-quarter revenue and EPS beat estimates, but stock remains stagnant.

The Motley Fool’s analyst team uncovered the top 10 stocks to buy now, with Thermo Fisher Scientific potentially making the list. Stock Advisor has outperformed the S&P by 892.04%, with past recommendations like Netflix and Nvidia yielding significant returns. Don’t miss out on future opportunities by joining Stock Advisor for the latest top 10 list.

Read more at Yahoo Finance: Why Thermo Fisher Scientific Stock Was Topping the Market Today